Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

SRK Capital's investment thesis on Solésence, Inc. ($SLSN) — Q2 2025 | Buyside Digest

All Pitches

View Letter Analysis

$SLSNNASDAQSolésence, Inc.

BULL

SRK Capital—SLSN

Fund Letter

Q2 2025

Published August 1, 2025

View Fund Profile

$0.82USD

-3.5% vs last month

$3.32Pitched

-75.3% since pitch

Market Cap$74.2M

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

SRK Fund I, LP returned a stellar 46.94% during the first half of 2025, vastly outperforming the S&P 500 (6.20%) and Russell 2000 (-1.78%). ISSC and SLSN...

— Sean Kirkwood

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $SLSN, and what else SRK Capital is buying.

Other pitches on $SLSN

Other investors who've written on Solésence, Inc.

No other institutional pitches found for this ticker yet.

View all $SLSN pitches →